PathPresenter

PathPresenter

Pathology & Laboratory Diagnostics

About PathPresenter

PathPresenter is a comprehensive digital pathology image management system built by pathologists for pathologists. Founded by decorated pathologist and digital pioneer Dr. Raj Singh, PathPresenter delivers an enterprise-grade platform that addresses clinical performance, workflow flexibility, AI readiness, enterprise integration, education leadership, and institutional data value. The platform has been battle-tested through 300,000+ hours of real-world usage by tens of thousands of users across leading tier-one institutions globally. PathPresenter's core offering includes FDA 510(k)-cleared and CE-IVDR certified clinical viewers for primary diagnosis, along with integrated modules for remote consultations (ConsultConnect), pathology education, and biorepository management. The platform takes a 100% vendor-agnostic approach, supporting any scanner, file format, storage platform, LIS system, and AI model. This flexibility enables seamless integration across complex healthcare IT environments while maintaining unsurpassed rendering speed even with high numbers of simultaneous users. The company also operates PathPresenter Public, the world's largest free platform for pathology education with over 60,000 users accessing lessons, lectures, and curated cases. PathPresenter powers the College of American Pathologists' innovative AI Studio, where members can test-drive cutting-edge AI tools from multiple vendors. Through strategic partnerships with leading AI, scanner, storage, and healthcare IT vendors, PathPresenter is building the infrastructure to connect pathologists, institutions, and pharma companies for seamless image data sharing, AI algorithm deployment, and domain expertise exchange.

Mission & Story

Mission

Democratize access to the world's pathology knowledge

Founding Story

Founded by decorated pathologist and digital pioneer Dr. Raj Singh. The platform was shaped by deep domain knowledge and designed to solve problems that other vendors have struggled to address, built in the most demanding real-world environments.

Clinical Focus

Medical conditions and clinical areas addressed by PathPresenter.

OncologyDermatopathologyGeneral pathology across all subspecialties

Who It Serves

Health SystemsAcademic Medical CentersCancer CentersPathology LaboratoriesPharma CompaniesResearch Institutions

Milestones & Awards

Recent Milestones

New Biorepository Management module launched; ConsultConnect zero-footprint portal for remote second opinions announced; General availability on AWS; $7.5M funding round led by Avant Bio, Barco, and Modi Ventures; CAP AI Studio launch

Awards & Recognition

Powers College of American Pathologists' AI Studio; Featured in Microsoft Azure customer success story

Key Partnerships

College of American Pathologists (CAP)BarcoHamamatsuPrimaaVoicebrookLigoLabPictor LabsAiforiaPaigeAisenciaIbexBlind ReviewPramanaMicrosoft AzureAmazon Web ServicesWorld Tumor RegistryImagenomixAvant BioModi Ventures

Company Details

Headquarters
Montville, NJ, USA

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

FDA 510(k)CE-IVDRHIPAA implied
Last updated Jul 1, 2026

Similar Companies in this Market

View all 45
Aiforia

Aiforia

Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.

Aignostics

Aignostics

Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.

Aiosyn

Aiosyn

Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.

AIxMed

AIxMed

AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.

Akoya Biosciences

Akoya Biosciences

Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.

Caris Life Sciences

Caris Life Sciences

Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.

CellaVision

CellaVision

201-500 employees

CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.

Clever Culture Systems

Clever Culture Systems

Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.